Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study
Background: High lipoprotein(a) is associated with poor prognosis in patients at high risk for cardiovascular disease. Renal function based on the estimated glomerular filtration rate (eGFR) is a potential risk factor for the change of lipoprotein(a). However, the regulatory effect of eGFR stratific...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/91a5f791d5dd4a6ab0b797c88b798569 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:91a5f791d5dd4a6ab0b797c88b798569 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:91a5f791d5dd4a6ab0b797c88b7985692021-11-17T05:15:53ZAssociation of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study2297-055X10.3389/fcvm.2021.747120https://doaj.org/article/91a5f791d5dd4a6ab0b797c88b7985692021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.747120/fullhttps://doaj.org/toc/2297-055XBackground: High lipoprotein(a) is associated with poor prognosis in patients at high risk for cardiovascular disease. Renal function based on the estimated glomerular filtration rate (eGFR) is a potential risk factor for the change of lipoprotein(a). However, the regulatory effect of eGFR stratification on lipoprotein(a)-associated mortality has not been adequately addressed.Methods: 51,500 patients who underwent coronary angiography (CAG) or percutaneous coronary intervention (PCI) were included from the Cardiorenal ImprovemeNt (CIN) study (ClinicalTrials.gov NCT04407936). These patients were grouped according to lipoprotein(a) quartiles (Q1–Q4) stratified by eGFR categories (<60 and ≥60 mL/min/1.73m2). Cox regression models were used to estimate hazard ratios (HR) for mortality across combined eGFR and lipoprotein(a) categories.Results: The mean age of the study population was 62.3 ± 10.6 years, 31.3% were female (n = 16,112). During a median follow-up of 5.0 years (interquartile range: 3.0–7.6 years), 13.0% (n = 6,695) of patients died. Compared with lipoprotein(a) Q1, lipoprotein(a) Q2–Q4 was associated with 10% increased adjusted risk of death in all patients (HR: 1.10 [95% CI: 1.03–1.17]), and was strongly associated with about 23% increased adjusted risk of death in patients with eGFR <60 mL/min/1.73m2 (HR: 1.23 [95% CI: 1.08–1.39]), while such association was not significant in patients with eGFR ≥60 mL/min/1.73m2 (HR: 1.05 [95% CI: 0.97–1.13]). P for interaction between lipoprotein(a) (Q1 vs. Q2–Q4) and eGFR (≥60 vs. eGFR <60 mL/min/1.73m2) on all-cause mortality was 0.019.Conclusions: Elevated lipoprotein(a) was associated with increased risk of all-cause mortality and such an association was modified by the baseline eGFR in CAG patients. More attention should be paid to the patients with reduced eGFR and elevated lipoprotein(a), and the appropriate lipoprotein(a) intervention is required.Zhidong HuangYanfang YangYanfang YangJin LuJin LuJingjing LiangYibo HeYaren YuHaozhang HuangQiang LiBo WangShanggang LiZelin YanDanyuan XuYong LiuKaihong ChenZhigang HuangJindong NiJin LiuLiling ChenShiqun ChenFrontiers Media S.A.articlelipoprotein(a)estimated glomerular filtration rateall-cause mortalitycoronary angiographyrenal functionDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
lipoprotein(a) estimated glomerular filtration rate all-cause mortality coronary angiography renal function Diseases of the circulatory (Cardiovascular) system RC666-701 |
| spellingShingle |
lipoprotein(a) estimated glomerular filtration rate all-cause mortality coronary angiography renal function Diseases of the circulatory (Cardiovascular) system RC666-701 Zhidong Huang Yanfang Yang Yanfang Yang Jin Lu Jin Lu Jingjing Liang Yibo He Yaren Yu Haozhang Huang Qiang Li Bo Wang Shanggang Li Zelin Yan Danyuan Xu Yong Liu Kaihong Chen Zhigang Huang Jindong Ni Jin Liu Liling Chen Shiqun Chen Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study |
| description |
Background: High lipoprotein(a) is associated with poor prognosis in patients at high risk for cardiovascular disease. Renal function based on the estimated glomerular filtration rate (eGFR) is a potential risk factor for the change of lipoprotein(a). However, the regulatory effect of eGFR stratification on lipoprotein(a)-associated mortality has not been adequately addressed.Methods: 51,500 patients who underwent coronary angiography (CAG) or percutaneous coronary intervention (PCI) were included from the Cardiorenal ImprovemeNt (CIN) study (ClinicalTrials.gov NCT04407936). These patients were grouped according to lipoprotein(a) quartiles (Q1–Q4) stratified by eGFR categories (<60 and ≥60 mL/min/1.73m2). Cox regression models were used to estimate hazard ratios (HR) for mortality across combined eGFR and lipoprotein(a) categories.Results: The mean age of the study population was 62.3 ± 10.6 years, 31.3% were female (n = 16,112). During a median follow-up of 5.0 years (interquartile range: 3.0–7.6 years), 13.0% (n = 6,695) of patients died. Compared with lipoprotein(a) Q1, lipoprotein(a) Q2–Q4 was associated with 10% increased adjusted risk of death in all patients (HR: 1.10 [95% CI: 1.03–1.17]), and was strongly associated with about 23% increased adjusted risk of death in patients with eGFR <60 mL/min/1.73m2 (HR: 1.23 [95% CI: 1.08–1.39]), while such association was not significant in patients with eGFR ≥60 mL/min/1.73m2 (HR: 1.05 [95% CI: 0.97–1.13]). P for interaction between lipoprotein(a) (Q1 vs. Q2–Q4) and eGFR (≥60 vs. eGFR <60 mL/min/1.73m2) on all-cause mortality was 0.019.Conclusions: Elevated lipoprotein(a) was associated with increased risk of all-cause mortality and such an association was modified by the baseline eGFR in CAG patients. More attention should be paid to the patients with reduced eGFR and elevated lipoprotein(a), and the appropriate lipoprotein(a) intervention is required. |
| format |
article |
| author |
Zhidong Huang Yanfang Yang Yanfang Yang Jin Lu Jin Lu Jingjing Liang Yibo He Yaren Yu Haozhang Huang Qiang Li Bo Wang Shanggang Li Zelin Yan Danyuan Xu Yong Liu Kaihong Chen Zhigang Huang Jindong Ni Jin Liu Liling Chen Shiqun Chen |
| author_facet |
Zhidong Huang Yanfang Yang Yanfang Yang Jin Lu Jin Lu Jingjing Liang Yibo He Yaren Yu Haozhang Huang Qiang Li Bo Wang Shanggang Li Zelin Yan Danyuan Xu Yong Liu Kaihong Chen Zhigang Huang Jindong Ni Jin Liu Liling Chen Shiqun Chen |
| author_sort |
Zhidong Huang |
| title |
Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study |
| title_short |
Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study |
| title_full |
Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study |
| title_fullStr |
Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study |
| title_full_unstemmed |
Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study |
| title_sort |
association of lipoprotein(a)-associated mortality and the estimated glomerular filtration rate level in patients undergoing coronary angiography: a 51,500 cohort study |
| publisher |
Frontiers Media S.A. |
| publishDate |
2021 |
| url |
https://doaj.org/article/91a5f791d5dd4a6ab0b797c88b798569 |
| work_keys_str_mv |
AT zhidonghuang associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT yanfangyang associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT yanfangyang associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT jinlu associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT jinlu associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT jingjingliang associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT yibohe associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT yarenyu associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT haozhanghuang associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT qiangli associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT bowang associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT shanggangli associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT zelinyan associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT danyuanxu associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT yongliu associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT kaihongchen associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT zhiganghuang associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT jindongni associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT jinliu associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT lilingchen associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy AT shiqunchen associationoflipoproteinaassociatedmortalityandtheestimatedglomerularfiltrationratelevelinpatientsundergoingcoronaryangiographya51500cohortstudy |
| _version_ |
1718425940284932096 |